Loading...
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
This study investigated whether rosiglitazone may affect breast cancer risk in female patients with type 2 diabetes mellitus in Taiwan. The reimbursement database of all female patients with type 2 diabetes mellitus under oral antidiabetic agents or insulin from 1996 to 2009 was retrieved from the N...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356862/ https://ncbi.nlm.nih.gov/pubmed/27936468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13824 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|